Form 8-K - Current report:
SEC Accession No. 0001193125-26-201751
Filing Date
2026-05-01
Accepted
2026-05-01 17:27:31
Documents
9
Period of Report
2026-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K olma-20260427.htm   iXBRL 8-K 46267
  Complete submission text file 0001193125-26-201751.txt   152678

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT olma-20260427.xsd EX-101.SCH 24998
12 EXTRACTED XBRL INSTANCE DOCUMENT olma-20260427_htm.xml XML 4749
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 26933913
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)